Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Farmers Insurance
Express Scripts
US Army
Medtronic
Cerilliant
US Department of Justice
Argus Health

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091239

« Back to Dashboard

Summary for 091239
Tradename:IBUPROFEN
Applicant:Marksans Pharma
Ingredient:ibuprofen
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 091239
Suppliers and Packaging for NDA: 091239
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IBUPROFEN ibuprofen TABLET;ORAL 091239 ANDA Weeks & Leo Co., Inc. 11383-151 N 11383-151-11
IBUPROFEN ibuprofen TABLET;ORAL 091239 ANDA Weeks & Leo Co., Inc. 11383-151 N 11383-151-21

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength200MG
Approval Date:Feb 1, 2011TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Fuji
Citi
Harvard Business School
Deloitte
QuintilesIMS
Queensland Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.